| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/24/2005 | US20050042178 Calcitonin gene-related peptide antagonists; stable, spray-dried microparticles; analgesic for headaches; improved bioavailability |
| 02/24/2005 | US20050042177 Nanoparticles with a particle size less than 2 microns, and having a surface stabilizer; improved consistency in bioabsorption |
| 02/24/2005 | US20050042175 Combined doses of formoterol and budesonide |
| 02/24/2005 | US20050042174 Consistent inhalation dry powder metered doses; concurrent delivery of bronchodilator, anticholinergic agent and antiinflammatory steroid |
| 02/24/2005 | US20050042173 Pharmaceuticals, cosmetics or nutraceuticals with a bioadhesive and plasticizer on a biodegradable support for transdermal or transmucosal application |
| 02/24/2005 | US20050042172 Administration of medicaments by vaporisation |
| 02/24/2005 | US20050042171 Only once daily administration of an antispasmodic beta-2 adrenergic agonist and an antiinflammatory corticosteroid; inhalation; salmeterol xinafoate |
| 02/24/2005 | US20050042170 Method and device for generating mists and medical uses thereof |
| 02/24/2005 | US20050039743 Medicament dispenser |
| 02/24/2005 | DE19828273B4 Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 02/24/2005 | DE10335231A1 Verfahren zur Verbesserung der Durchlässigkeit der menschlichen Haut A method for improving the permeability of human skin |
| 02/24/2005 | DE10333497A1 Sustained release composition useful in the treatment of e.g. benign prostatic hyperplasia comprises Tamsulosin core with a coating containing combination of polyvinyl acetate and polyvinyl pyrrolidone |
| 02/24/2005 | DE10333393A1 Transdermales Therapeutisches System mit dem Wirkstoff Pramipexol Transdermal therapeutic system with the active ingredient pramipexole |
| 02/24/2005 | DE10333384A1 Mixing apparatus producing technical, cosmetic and pharmaceutical fluid- and semi-solid products, comprises two or more vessels connected by multi-way path |
| 02/24/2005 | DE10330768A1 Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von inhalierbaren Arzneimitteln zur Prophylaxe und Behandlung pulmonaler und kardiovaskulärer Erkrankungen, sowie eines Osmolyte als Wirkstoffbestandteil enthaltende Inhalationsvorrichtung The use of products derived from extremophilic bacteria osmolytes for the production of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases, as well as a osmolytes containing as active ingredient inhalation device |
| 02/24/2005 | CA2576060A1 Macrolides containing oil-in-water emulsions |
| 02/24/2005 | CA2535846A1 Adhesive bioerodible transmucosal drug delivery system |
| 02/24/2005 | CA2535619A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | CA2535554A1 Methods for reducing astringency |
| 02/24/2005 | CA2535398A1 Antibiotic product, use and formulation thereof |
| 02/24/2005 | CA2535177A1 Robust pellet |
| 02/24/2005 | CA2534985A1 Pharmaceutical metered dose inhaler and methods relating thereto |
| 02/24/2005 | CA2534932A1 Form of administration secured against misuse |
| 02/24/2005 | CA2534925A1 Dosage form that is safeguarded from abuse |
| 02/24/2005 | CA2534924A1 Novel metaxalone compositions |
| 02/24/2005 | CA2534922A1 Composition comprising a zeolite compound for treatment of diseases |
| 02/24/2005 | CA2534920A1 Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation |
| 02/24/2005 | CA2534897A1 Process of making flowable hemostatic compositions and devices containing such compositions |
| 02/24/2005 | CA2534895A1 Hemostatic compositions containing sterile thrombin |
| 02/24/2005 | CA2533924A1 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 02/24/2005 | CA2533637A1 Polymersomes incorporating highly emissive probes |
| 02/24/2005 | CA2532110A1 Process for the purification of non-ionic solvents for stabilized injectable pharmaceutical formulations |
| 02/24/2005 | CA2525228A1 Molecules enhancing dermal delivery of influenza vaccines |
| 02/24/2005 | CA2524921A1 Method and composition for treating burned skin |
| 02/23/2005 | EP1508591A1 Wrapping material for seamless capsules |
| 02/23/2005 | EP1508338A1 Mycobacterial protein antigens for cancer therapy and vaccination |
| 02/23/2005 | EP1508332A1 Medicinal composition |
| 02/23/2005 | EP1508331A1 Method for preparing polymer micelle pharmaceutical preparation containing drug for injection |
| 02/23/2005 | EP1508330A1 Inhalation capsules |
| 02/23/2005 | EP1508329A1 Composition for an antifungal agent for suppressing fungal growth in an oral cavity |
| 02/23/2005 | EP1507851A1 Method for assembling sub units into capsoides |
| 02/23/2005 | EP1507826A2 Amelioration of the development of cataracts and other opthalmic diseases |
| 02/23/2005 | EP1507718A1 Container for the generation of therapeutic microfoam |
| 02/23/2005 | EP1507559A1 Delivery of microparticle-conjugated drugs for inhibition of stenosis |
| 02/23/2005 | EP1507556A2 Calicheamicin derivative-carrier conjugates |
| 02/23/2005 | EP1507544A1 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 02/23/2005 | EP1507538A1 Norethindrone sustained release formulations and methods associated therewith |
| 02/23/2005 | EP1507519A1 Medicament with delayed release of the active substance, containing 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol |
| 02/23/2005 | EP1507518A1 Combination immediate release controlled release levodopa/carbidopa dosage forms |
| 02/23/2005 | EP1507517A1 Microparticles bearing cells and active substances |
| 02/23/2005 | EP1507516A1 Co-grinding process for the preparation of a ternary composition |
| 02/23/2005 | EP1507515A2 Free-flowing, powdery composition containing alpha-liponic acid (-derivatives) |
| 02/23/2005 | EP1507514A2 Controlled release compositions of estradiol metabolites |
| 02/23/2005 | EP1507513A1 Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol |
| 02/23/2005 | EP1507455A1 Antimicrobial envelopes |
| 02/23/2005 | EP1313489B1 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome |
| 02/23/2005 | EP1221919B1 Ophthalmic drug delivery device |
| 02/23/2005 | EP1207757B1 Ectoparasiticidal aqueous suspension formulations of spinosyns |
| 02/23/2005 | EP1017381B1 Butyrate derivatives in the treatment of fibromyalgia and chronic fatigue syndrome |
| 02/23/2005 | EP0689454B2 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| 02/23/2005 | CN2680291Y Drug plaster capable of eliminating toxin and treating disease |
| 02/23/2005 | CN2680261Y Anti-inflammatory plaster |
| 02/23/2005 | CN1585767A Dimeric compounds and their use as anti-viral agents |
| 02/23/2005 | CN1585765A Dimeric compounds and their use as anti-viral agents |
| 02/23/2005 | CN1585764A Dimeric compounds and their use as anti-viral agents |
| 02/23/2005 | CN1585650A 可食性薄膜 Edible film |
| 02/23/2005 | CN1585647A Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases |
| 02/23/2005 | CN1585644A Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
| 02/23/2005 | CN1585642A Pharmaceutical compositions containing 3, 4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 02/23/2005 | CN1585635A 2-(4-isobutylphenyl) propionic acid medicinal composition |
| 02/23/2005 | CN1585632A Coated capsule |
| 02/23/2005 | CN1585631A Process for preparing quick dissolving, high loading ribavirin compositions |
| 02/23/2005 | CN1585630A Method for the formation of ibuprofen crystals |
| 02/23/2005 | CN1585629A Carotenoid composition and method for protecting skin |
| 02/23/2005 | CN1585627A Microfabricated nanopore device for sustained release of therapeutic agent |
| 02/23/2005 | CN1585475A Subtitling transmission system |
| 02/23/2005 | CN1583799A Extraction for radix cynanchi bungei polysaccharide and oral lozenge preparation |
| 02/23/2005 | CN1583735A Enrichment of ligusticum lactone and its preparations |
| 02/23/2005 | CN1583175A Skin targeting medicinal composition and its preparation and use |
| 02/23/2005 | CN1583174A Long-term injection containing ethylcellulose and fatty acid ester |
| 02/23/2005 | CN1583173A Serial medicines for hypertension and method for research, application and production |
| 02/23/2005 | CN1583172A Multifunctional liquid for clean therapy of nasal cavity and sinuses |
| 02/23/2005 | CN1583170A Medicine for human lysozyme against virus and drug-fast bacteria and its preparation |
| 02/23/2005 | CN1583169A Use of human lysozyme in preparation of medicine for hemorrhoid |
| 02/23/2005 | CN1583168A Use of human lysozyme in preparation of medicine for unhealed ulceration by wound inflammation |
| 02/23/2005 | CN1583167A Use of recommbined human lysozyme in preparation of medicine for bronchial asthma |
| 02/23/2005 | CN1583166A Chinese forest frog bactericidal peptide spray agent and its preparation |
| 02/23/2005 | CN1583165A Gel gent of Chiense forest frog bactericidal peptide |
| 02/23/2005 | CN1583163A Preparing procedure for enteric soluble capsules of transfer factor |
| 02/23/2005 | CN1583159A Health care products of lucid ganoderma and their preparation |
| 02/23/2005 | CN1583155A Health care and refreshing brain towel treated with Chinse medicinal solution and its production |
| 02/23/2005 | CN1583154A Oral liquid and capsules of Chinese medicine for diabete by supplementing Qi and nourishing Yin and promotnig production of body fluid and quenching thirst |
| 02/23/2005 | CN1583152A Anti-virus capsules of Jinhao |
| 02/23/2005 | CN1583148A Preparation of oriental waterplantain pieces |
| 02/23/2005 | CN1583147A Preparation of oriental waterplantain pieces |
| 02/23/2005 | CN1583146A Preparation and preparing method for asthenia diseases of breath and blood circulation systems |
| 02/23/2005 | CN1583142A Pills for promoting blood circulation and removing obstruction in channels |
| 02/23/2005 | CN1583140A Preparation and use of dragon's blood disintegrants |
| 02/23/2005 | CN1583139A Preparation of dragon's blood and phospholipin composition |
| 02/23/2005 | CN1583137A Medicinal composition for apoplexy and its sequel and its preparation |